Insider Transactions in Q1 2021 at Solid Biosciences Inc. (SLDB)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 23
2021
|
Adam Koppel |
BUY
Grant, award, or other acquisition
|
Indirect |
869,565
+9.88%
|
$4,347,825
$5.75 P/Share
|
Mar 23
2021
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
2,608,695
+16.28%
|
$13,043,475
$5.75 P/Share
|
Mar 19
2021
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
2,206,685
+16.82%
|
$11,033,425
$5.75 P/Share
|
Mar 12
2021
|
Joel Solomon Zev Schneider Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
23,398
-4.09%
|
$187,184
$8.84 P/Share
|
Mar 12
2021
|
Carl Ashley Morris Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
23,398
-3.99%
|
$187,184
$8.85 P/Share
|
Feb 12
2021
|
Ilan Ganot |
SELL
Open market or private sale
|
Indirect |
457
-13.12%
|
$3,199
$7.66 P/Share
|
Jan 28
2021
|
Ilan Ganot |
SELL
Open market or private sale
|
Direct |
10,713
-0.89%
|
$64,278
$6.14 P/Share
|
Jan 28
2021
|
Carl Ashley Morris Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,459
-1.14%
|
$20,754
$6.14 P/Share
|
Jan 28
2021
|
Jennifer Lynn Ziolkowski CFO, Treasurer & Asst. Secy |
SELL
Open market or private sale
|
Direct |
3,473
-1.02%
|
$20,838
$6.14 P/Share
|
Jan 28
2021
|
Joel Solomon Zev Schneider Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,443
-1.16%
|
$20,658
$6.14 P/Share
|
Jan 27
2021
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Direct |
35,500
+2.85%
|
-
|
Jan 27
2021
|
Carl Ashley Morris Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+3.66%
|
-
|
Jan 27
2021
|
Jennifer Lynn Ziolkowski CFO, Treasurer & Asst. Secy |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+3.28%
|
-
|
Jan 27
2021
|
Joel Solomon Zev Schneider Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+3.74%
|
-
|